Description

The Genetic Technology TechVision Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across precision medicine. Precision medicine strategies targeting mRNA splicing, novel therapies for inherited disorders, microbiome-based therapies for inflammatory diseases, and gene editing technologies fueling personalized medicine are detailed. Clinical trials scenario related to CRISPR-based technologies is also depicted.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Precision medicine, mRNA splicing, inherited deafness, microbiome-based therapy, inflammatory bowel disease, gene editing, CRISPR